论文部分内容阅读
目的:观察联合使用麝香保心丸和倍他乐克治疗冠心病合并心功能不全(CHF)的临床疗效。方法:将60例CHF患者随机分成对照组和治疗组,每组各30例患者。为对照组患者常规使用利尿剂、强心药及ACEI等药物进行治疗,为治疗组患者在进行常规治疗的基础上使用麝香保心丸和倍他乐克进行治疗。结果:与对照组患者相比,治疗组患者在减慢心率、降低血压、改善心功能等方面取得的疗效更为显著。治疗组患者治疗的总有效率为96.6%,对照组患者治疗的总有效率为83.3%。两组患者治疗的总有效率相比较,差异显著(p﹤0.05),有统计学意义。结论:联合使用麝香保心丸和倍他乐克对冠心病合并心功能不全患者进行中西医结合治疗可取得显著的疗效,值得在临床上推广使用。
Objective: To observe the clinical efficacy of combined use of Shexiang Baoxin Pill and Betaloc on patients with coronary heart disease complicated with heart failure (CHF). Methods: Sixty CHF patients were randomly divided into control group and treatment group, with 30 patients in each group. Patients in the control group were treated with drugs such as diuretics, cardiotonic drugs and ACEI routinely. Patients in the treatment group were treated with Shexiang Baoxin and Betaloc on the basis of routine treatment. Results: Compared with the control group, the treatment group patients achieved more significant effects in reducing heart rate, lowering blood pressure and improving heart function. The total effective rate of the treatment group was 96.6%, while that of the control group was 83.3%. There was significant difference (p <0.05) between the two groups in the total effective rate of treatment, with statistical significance. Conclusion: The combination of Shexiang Baoxin Pill and Betaloc on Chinese patients with coronary heart disease complicated with cardiac insufficiency can achieve a significant effect, which is worth to be popularized in clinic.